Commerce Bank Invests $4.11 Million in Synopsys, Inc. $SNPS

Commerce Bank bought a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 9,208 shares of the semiconductor company’s stock, valued at approximately $4,107,000.

Other large investors have also added to or reduced their stakes in the company. Sankala Group LLC purchased a new stake in shares of Synopsys during the fourth quarter valued at about $25,000. Elevation Wealth Partners LLC raised its stake in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after acquiring an additional 27 shares in the last quarter. IMG Wealth Management Inc. bought a new position in shares of Synopsys during the 2nd quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in Synopsys during the fourth quarter valued at approximately $28,000. Finally, Atlas Capital Advisors Inc. acquired a new stake in Synopsys in the fourth quarter valued at approximately $32,000. 85.47% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on SNPS shares. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a report on Wednesday, August 19th. Weiss Ratings restated a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. Wells Fargo & Company lowered their target price on Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. Bank of America lifted their price objective on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 target price on shares of Synopsys in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Synopsys presently has an average rating of “Moderate Buy” and a consensus target price of $563.59.

Check Out Our Latest Research Report on Synopsys

Synopsys Stock Performance

SNPS opened at $394.51 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The company has a market cap of $75.54 billion, a price-to-earnings ratio of 91.32, a PEG ratio of 2.34 and a beta of 1.23. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $615.79. The firm’s fifty day simple moving average is $418.53 and its two-hundred day simple moving average is $439.92.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter last year, the business earned $3.67 earnings per share. The company’s revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.